Serial analysis of hepatitis B virus core nucleotide sequence of patients with acute exacerbation during chronic infection

Journal of Medical Virology

Volumn 49, Issue 2, 1996, Pages 103-109

  Okumura, Akihiko ^a   Takayanagi, Masahiro ^a   Aiyama, Toshiyuki ^a   Iwata, Kazuo ^a   Wakita, Takaji ^a   Ishikawa, Tetsuya ^a   Yoshioka, Kentaro ^a   Kakumu, Shinichi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Amino acid divergency; HBV core gene; HLA A2 chronic liver disease

Indexed keywords

HLA A2 ANTIGEN;

AMINO ACID SEQUENCE; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; VIRUS CORE;

ADULT; AMINO ACID SEQUENCE; BASE SEQUENCE; CHRONIC DISEASE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; VIRAL CORE PROTEINS;

HEPATITIS B VIRUS;

EID: 0029943867     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199606)49:2<103::AID-JMV6>3.0.CO;2-9     Document Type: Article

References (30)

1. Ackrill AM, Naoumov NV, Eddleston ALWF, Williams R (1993): Specific deletions in the hepatitis B virus core open reading frame in patients with chronic active hepatitis B. Journal of Medical Virology 41: 165-169.
2. Akarca US, Lok ASF (1995): Naturally occurring hepatitis B virus core gene mutations. Hepatology 22:50-60.
3. Bertoletti A, Ferrari C, Fiaccadori F, Penna A, Margolskee R, Schlicht HJ, Fowler P, Guilhot S, Chisari FV (1991): HLA class I-restricted human cytotoxic T cells recognize endogeneously synthesized hepatitis B virus nucleocapsid antigen. Proceeding of the National Academy of Sciences of the United States of America 88:10445-10449.
4. Bertoletti A, Chisari FV, Penna A, Guilhot S, Galati L, Missale G, Fowler P, Schlicht HJ, Vitiello A, Chesnut RC, Fiaccadori F, Ferrari C (1993): Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein. Journal of Virology 67:2376-2380.
5. Bertoletti A, Sette A, Chisari FV, Penna A, Levrero M, De Cash M, Fiaccadori F, Ferrari C (1994): Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369:407-410.
6. Carman WF, McIntyre G, Hadziyannis S, Fattovich G, Alberti A, Thomas HC (1993): Core protein evolution after selection of hepatitis B precore mutants and correlation with disease severity. In Nashioka K, Suzuki H, Mishiro S, Oda T (eds): "Viral Hepatitis and Liver Disease." Tokyo: Springer-Verlag, pp 273-276.
7. Carman WF, Thursz M, Hadziyannis S, McIntyre G, Colman K, Gioustoz A, Fattovich G, Alberti A, Thomas HC (1995): Hepatitis-B e-antigen negative chronic hepatitis: Hepatitis B virus core mutations occur predominantly in known antigenic determinants. Journal of Viral Hepatitis 2:77-84.
8. Chuang WL, Omata M, Ehata T, Yokosuka O, Ohto M (1993): Concentrating missense mutations in core gene of hepatitis B virus. Digestive Diseases and Sciences 38:594-600.
9. Colucci G, Beazer Y, Cantaluppi C, Tackney C (1988): Identification of major hepatitis B core antigen (HBcAg) determinant by synthetic peptides and monoclonal antibodies. Journal of Immunology 141: 4376-4380.
10. Ehata T, Omata M, Yokosuka O, Hosoda K, Ohto M (1992): Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection. Journal of Clinical Investigation 89:332-338.
11. Engelhard VH, Appela E, Benjamin DC, Bodnar WM, Cox AL, Chen Y, Henderson RA, Huczko EL, Michel H, Sakaguchi K, Shabanowitz J, Sevilir N, Slingluff C, Hunt DF (1993): Mass spectrometric analysis of peptides associated with the human class I MHC molecules HLA-A2.1 and HLA-B7 and identification of structural features that determine binding. Chemical Immunology 57:39-62.
12. Ferrari C, Penna A, Bertoletti A, Valli A, Antoni AD, Giuberti T, Cavalli A, Petit MA, Fiaccadori F (1990): Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. Journal of Immunology 145:3442-3449.
13. Ferrari C, Bertoletti A, Penna A, Cavalli A, Valli A, Missale G, Pilli M, Fowler P, Giuberti T, Chisari FV, Fiaccadori F (1991): Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. Journal of Clinical Investigation 88:214-222.
14. Liao W, Ou JH (1995): Phosphorylation and nuclear localization of the hepatitis B virus core protein: Significance of serine in the three repeated SPRRR motifs. Journal of Virology 69:1025-1029.
15. Lok ASF, Akarca U, Greene S (1994): Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proceeding of the National Academy of Sciences of the United States of America 91:4077-4081.
16. Maccario R, Comoli P, Percivalle E, Montagna D, Locatelli F, Gerna G (1995): Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either γδ or αβ T cell receptor: Role of accessory molecules on HLA-unrestricted killing of virus-infected targets. Immunology 85:49-56.
17. Milich DR, Hughes JL, Houghten R, McLachlan A, Jones JE (1989): Functional identification of agretopic residues within an HBcAg T cell determinant. Journal of Immunology 143:3141-3147.
18. Missale G, Redeker A, Person J, Fowler P, Guilhot S, Schlicht HJ, Ferrari C, Chisari FV (1993): HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. Journal of Experimental Medicine 177:751-762.
19. Okamoto H, Imai M, Shimozaki M, Hoshi Y, Iizuka H, Gotanda T, Tsuda F, Miyakawa Y, Mayumi M (1986): Nucleotide sequence of a cloned hepatitis B virus genome, subtype ayr: Comparison with genomes of the other three subtypes. Journal of General Virology 67:2305-2314.
20. Ono Y, Onda H, Sasada R, Igarashi K, Sugino Y, Nishioka K (1983): The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw. Nucleic Acids Research 11:1747-1757.
21. Penna A, Chisari FV, Bertoletti A, Missale G, Fowler P, Giuberti T, Fiaccadori F, Ferrari C (1991): Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. Journal of Experimental Medicine 174:1565-1570.
22. Pircher H, Moskophidis D, Rohrer U, Burki K, Hengartner H, Zinkernagel (1990): Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346:629-633.
23. Pollicino T, Campo S, Raimond G (1995): PreS and core gene heterogeneity in hepatitis B virus (HBV) genomes isolated from patients with long lasting HBV chronic infection. Virology 208:672-677.
24. Salfeld J, Pfaff E, Noah M, Schaller H (1989): Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. Journal of Virology 63:798-808.
25. Sjogren M, Hoofnagle JH (1985): Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitis. Gastroenterology 89:252-258.
26. Takayanagi M, Kakumu S, Ishikawa T, Higashi Y, Yoshioka K, Wakita T (1993): Comparison of envelope and Precore/Core variants of hepatitis B virus (HBV) during chronic HBV infection. Virology 196:138-145.
27. Tiollais P, Pourcel C, Dejean A (1985): The hepatitis B virus. Nature 317:489-495.
28. Tordjeman M, Fontan G, Rabillon V, Martin J, Trepo C, Hoffenbach A, Mabrouk K, Sabatier JM, Rietschoten JV, Somme G (1993): Characterization of minor and major antigenic regions within the hepatitis B virus nucleocapsid. Journal of Medical Virology 41: 221-229.
29. Vento S, Hegarty JE, Alberti A, O'Brien CJ, Alexander GJM, Eddleston ALWF, Williams R (1985): T lymphocyte sensitization to HBcAg and T cell mediated unresponsiveness to HBsAg in hepatitis B virusrelated chronic liver disease. Hepatology 5:192-197.
30. Wakita T, Kakumu S, Shibata M, Yoshioka K, Ito Y, Shinagawa T, Ishikawa T, Takayanagi M, Morishima T (1991): Detection of pre-C and core region mutants of hepatitis B virus in chronic hepatitis B virus carriers. Journal of Clinical Investigation 88:1793-1801.